MedPath

Ketorolac Tromethamine

These highlights do not include all the information needed to use KETOROLAC TROMETHAMINE safely and effectively. See full prescribing information for KETOROLAC TROMETHAMINE. KETOROLAC TROMETHAMINE ophthalmic solution 0.5% Initial U.S. Approval: 1991

Approved
Approval ID

2f27e304-7a96-47b6-8ef1-8a649c25abcf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 1, 2022

Manufacturers
FDA

Proficient Rx LP

DUNS: 079196022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ketorolac tromethamine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63187-777
Application NumberANDA076109
Product Classification
M
Marketing Category
C73584
G
Generic Name
ketorolac tromethamine
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateNovember 1, 2022
FDA Product Classification

INGREDIENTS (8)

KETOROLAC TROMETHAMINEActive
Quantity: 5 mg in 1 mL
Code: 4EVE5946BQ
Classification: ACTIB
OCTOXYNOL-40Inactive
Code: 9T1C662FKS
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ketorolac Tromethamine - FDA Drug Approval Details